| Literature DB >> 32601555 |
Ribal Bou Shaheen1, Mabelle Al Khoury2, Souad Seif2, Huneida Hamzeh2, Aouni Alameddine1.
Abstract
Neonatal suppurative parotitis (NSP) is a very rare disease of the salivary glands, usually involving the parotids. It is mostly due to Staphylococcus aureus bacterial infection among patients with predisposing factors, and management mainly relies on hydration and intravenous antibiotics with an excellent prognosis. Herein, we present a case of an 11-day-old female baby who presented with left periauricular edema and tenderness associated with fever that was later diagnosed as NSP due to both non-typable beta-hemolytic streptococci and Escherichia coli. Antibiotics therapy (vancomycin and gentamicin) was started, and the patient recovered completely after nine days. The CAse REport (CARE) guidelines were followed for reporting our case. Our case reiterates the fact that NSP should be in the differential diagnosis of any neonate presenting with fever and parotid area swelling. Prompt diagnosis is necessary for early management with antibiotics and to avoid complications.Entities:
Keywords: case report; escherichia coli; neonatal suppurative parotitis; non-typable beta-hemolytic streptococcus; salivary gland
Year: 2020 PMID: 32601555 PMCID: PMC7317125 DOI: 10.7759/cureus.8279
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1Ultrasound of the left parotid and preauricular region showing enlarged and edematous left parotid gland
(A) Left parotid gland with increased internal Doppler activity suggesting left parotitis. (B and C) The left parotid gland measured 3.66 × 1.57 cm
Antibiotic susceptibility profile of the non-typable beta-hemolytic streptococci and Escherichia coli
*Antibiotic used in patient treatment. Abbreviations: R, resistant; S, sensitive
| Antibiotics | Antibiotic susceptibility | |
| Non-typable beta-hemolytic streptococci | Escherichia coli | |
| Ampicillin | S | S |
| Amoxicillin/clavulanic acid | S | S |
| Cefalexin | S | S |
| Cefepime | S | S |
| Cefixime | S | S |
| Cefoxitin | S | S |
| Ceftazidime | S | S |
| Ceftriaxone | S | S |
| Cefuroxime | S | S |
| Piperacillin | S | S |
| Piperacillin/tazobactam | S | S |
| Ticarcillin | S | S |
| Imipenem | S | S |
| Meropenem | S | S |
| Ertapenem | S | S |
| Aztreonam | S | S |
| Amikacin | S | S |
| Gentamicin | S* | S* |
| Ciprofloxacin | S | S |
| Levofloxacin | S | S |
| Tigecycline | S | S |
| Trimethoprim/sulfamethoxazole | S | S |
| Penicillin | R | S |
| Vancomycin | S* | S* |
| Teicoplanin | S | S |
| Clindamycin | S | S |
| Erythromycin | R | S |
| Moxifloxacin | R | S |
| Tetracycline | R | S |